Cresco Labs’ Dispensary Launches Newly Enacted Illinois Opioid Alternative Pilot Program

Cresco Labs (CSE: CL) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that the Company’s FloraMedex dispensary launched Illinois’ Opioid Alternative Pilot Program (OAPP) today vastly expanding the population of Illinois patients who can access medical cannabis in place of pharmaceutical opioid medications. Under this new program, patients with doctor approval can receive near-immediate access to cannabis products from an Illinois licensed dispensary.

Continue Reading…

Source: Cresco Labs’ Dispensary Launches Newly Enacted Illinois Opioid Alternative Pilot Program